Generation of an Activating Zn2+Switch in the Dopamine Transporter: Mutation of an Intracellular Tyrosine Constitutively Alters the Conformational Equilibrium of the Transport Cycle
Binding of Zn2+to the endogenous Zn2+binding site in the human dopamine transporter leads to potent inhibition of [3H]dopamine uptake. Here we show that mutation of an intracellular tyrosine to alanine (Y335A) converts this inhibitory Zn2+switch into an activating Zn2+switch, allowing Zn2+-dependent...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 99; no. 3; pp. 1683 - 1688 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
National Academy of Sciences
05.02.2002
National Acad Sciences The National Academy of Sciences |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Binding of Zn2+to the endogenous Zn2+binding site in the human dopamine transporter leads to potent inhibition of [3H]dopamine uptake. Here we show that mutation of an intracellular tyrosine to alanine (Y335A) converts this inhibitory Zn2+switch into an activating Zn2+switch, allowing Zn2+-dependent activation of the transporter. The tyrosine is part of a conserved YXXΦ trafficking motif (X is any residue and Φ is a residue with a bulky hydrophobic group), but Y335A did not show alterations in surface targeting or protein kinase C-mediated internalization. Despite wild-type levels of surface expression, Y335A displayed a dramatic decrease in [3H]dopamine uptake velocity (Vmax) to less than 1% of the wild type. In addition, Y335A showed up to 150-fold decreases in the apparent affinity for cocaine, mazindol, and related inhibitors whereas the apparent affinity for several substrates was increased. However, the presence of Zn2+in micromolar concentrations increased the Vmaxup to 24-fold and partially restored the apparent affinities. The capability of Zn2+to restore transport is consistent with a reversible, constitutive shift in the distribution of conformational states in the transport cycle upon mutation of Tyr-335. We propose that this shift is caused by disruption of intramolecular interactions important for stabilizing the transporter in a conformation in which extracellular substrate can bind and initiate transport, and accordingly that Tyr-335 is critical for regulating isomerization between discrete states in the transport cycle. |
---|---|
Bibliography: | C.J.L. and L.N. contributed equally to this work. Edited by Arthur Karlin, Columbia University College of Physicians and Surgeons, New York, NY, and approved December 13, 2001 To whom reprint requests should be addressed. E-mail: gether@mfi.ku.dk. |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.032386299 |